Quarterly Financial Results
for the Biopharmaceuticals Segment
Current publicly reported financial results (in $millions) for selected companies in the biopharmaceutical segment. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Also, company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
Report for 2004